{"title": "Using genetics of human fat cells to predict response to anti-diabetes drugs", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/personalized_medicine.xml", "value": "Using genetics of human fat cells to predict response to anti-diabetes drugs"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/01/190110141816.htm"}], "link": "https://www.sciencedaily.com/releases/2019/01/190110141816.htm", "summary": "Researchers have demonstrated -- using fat cells derived from human stem cells -- that individual genetic variation can be used to predict whether the TZD rosiglitazone will produce the unwanted side effect of increasing cholesterol levels in certain individuals.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/personalized_medicine.xml", "value": "Researchers have demonstrated -- using fat cells derived from human stem cells -- that individual genetic variation can be used to predict whether the TZD rosiglitazone will produce the unwanted side effect of increasing cholesterol levels in certain individuals."}, "published": "Thu, 10 Jan 2019 14:18:16 EST", "published_parsed": [2019, 1, 10, 19, 18, 16, 3, 10, 0], "id": "https://www.sciencedaily.com/releases/2019/01/190110141816.htm", "guidislink": false}